Spain Biotechnology & Medical Research

Oryzon Genomics SA (ORY)

Oryzon Genomics SA has recorded no insider trading activity within the past ninety days. The most recent transaction occurred on September 21, 2022, when a director sold shares valued at 84,870 euros. Historical data indicates previous divestments by key personnel, though no significant market movements have been reported by company insiders for several years.
Ticker: ORY Exchange: MCE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oryzon Genomics SA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
EMILI TORRELL CORTADA DIRECTOR DE DESARROLLO DE NEGOCIO Officer
Transaction date
Sale
Price
315.38
Quantity 66,783
Value €4,654,662
Tamara Maes Consejera dominical Director
Transaction date
Sale
Price
164.72
Quantity 1,499
Value €3,608,293
Tamara Maes Consejera Director
Transaction date
Sale
Price
14.70
Quantity 66,631
Value €3,298,466
Carlos Manuel Buesa Arjol Consejero Director
Transaction date
Sale
Price
3.72
Quantity 250,000
Value €930,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-27 2022-09-21 S Sale
EMILI TORRELL CORTADA

DIRECTOR DE DESARROLLO DE NEGOCIO

Officer
66,783
315.38
€4,654,662 		66,783 315.38 €4,654,662
2021-02-27 2021-02-26 S Sale
Tamara Maes

Consejera dominical

Director
1,499
164.72
€3,608,293 		1,499 164.72 €3,608,293
2020-12-30 2020-12-29 S Sale
Tamara Maes

Consejera

Director
66,631
14.70
€3,298,466 		66,631 14.70 €3,298,466
2020-12-30 2020-12-29 S Sale
Carlos Manuel Buesa Arjol

Consejero

Director
250,000
3.72
€930,000 		250,000 3.72 €930,000
Explore more

More insider trading research around Oryzon Genomics SA

More insider trades in Spain
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe